Etiometry Inc. and the Brown-Lifespan Center for Digital Health (CDH) announce an agreement for joint clinical research and validation of the Etiometry Platform to collect data about the care of critically ill adult patients. The research partnership is expected to lead to groundbreaking advancements in Etiometry’s algorithms that assist clinicians in making data-driven decisions, providing better care for future patients.
Founded in 2020, the CDH leverages innovative technology to maximize health and eliminate health disparities at both a patient and population level. The CDH is designed to rapidly implement and scale digital treatment modalities in order to have broad and direct impact.
“This collaboration is a demonstration of the power of cooperation between clinicians, researchers, and industry partners to help patients,” according to Megan Ranney, M.D., Founding Director of the Brown-Lifespan Center for Digital Health.
Etiometry, a leader in clinical decision-support software, aids clinicians providing care to critically ill patients by using FDA-cleared algorithms to provide risk estimations of deterioration for each patient. By using data collected over time about the treatment and outcomes of patients, Etiometry will be able to advance its algorithms with information from eight adult units within Rhode Island Hospital and The Miriam Hospital.
“The new research partnership will allow Etiometry to build upon the hundreds of millions of hours of data collected with our platform,” said Shane Cooke, CEO and President of Etiometry. “Collaborating with the Brown-Lifespan Center for Digital Health will enable new and exciting clinical research pathways as well as validation of risk algorithms currently utilized in the pediatric critical care population. This partnership is vital to the growth of our platform and enables us to impact more patients across the continuum of care.”